UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial

Journal of clinical oncology, 2019-01, Vol.37 (3), p.178-189

2019

Volltextzugriff (PDF)

Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study

Journal of clinical oncology, 2009-04, Vol.27 (12), p.1999-2006

2009

Volltextzugriff (PDF)

Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis

Health technology assessment (Winchester, England), 2019-06, Vol.23 (30), p.1-328

2019

Volltextzugriff (PDF)

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

The lancet oncology, 2017-07, Vol.18 (7), p.929-945

2017

Volltextzugriff (PDF)

Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer

European journal of cancer (1990), 2011-10, Vol.47 (15), p.2273-2281

2011

Volltextzugriff (PDF)

Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework

Trials, 2018-01, Vol.19 (1), p.50-50, Article 50

2018

Volltextzugriff (PDF)

Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training

PloS one, 2020-09, Vol.15 (9), p.e0238593-e0238593

2020

Volltextzugriff (PDF)

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer

Health technology assessment (Winchester, England), 2016-02, Vol.20 (10), p.xxiii-202

2016

Volltextzugriff (PDF)

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others

JNCI : Journal of the National Cancer Institute, 2016-09, Vol.108 (9), p.djw050

2016

Volltextzugriff (PDF)

Economic Evaluation of Genomic Test-Directed Chemotherapy for Early-Stage Lymph Node-Positive Breast Cancer

JNCI : Journal of the National Cancer Institute, 2012-01, Vol.104 (1), p.56-66

2012

Volltextzugriff (PDF)

Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study

NPJ breast cancer, 2021-07, Vol.7 (1), p.90-13, Article 90

2021

Volltextzugriff (PDF)

Multistate Gene Cluster Switches Determine the Adaptive Mitochondrial and Metabolic Landscape of Breast Cancer

Cancer research (Chicago, Ill.), 2024-09, Vol.84 (17), p.2911-2925

2024

Volltextzugriff (PDF)

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

Journal of clinical epidemiology, 2019-02, Vol.106, p.108-120

2019

Volltextzugriff (PDF)

Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial

Value in health, 2017-12, Vol.20 (10), p.1311-1318

2017

Volltextzugriff (PDF)

Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches

Histopathology, 2015-09, Vol.67 (3), p.279-293

2015

Volltextzugriff (PDF)

Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation

The EMBO journal, 2003-08, Vol.22 (16), p.4178-4189

2003

Volltextzugriff (PDF)

OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions

European journal of surgical oncology, 2016-05, Vol.42 (5), p.S9-S10

2016

Volltextzugriff (PDF)

Proteomic Definition of Normal Human Luminal and Myoepithelial Breast Cells Purified from Reduction Mammoplasties

Proceedings of the National Academy of Sciences - PNAS, 1999-10, Vol.96 (22), p.12589-12594

1999

Volltextzugriff (PDF)

Abstract 7559: Multi-state gene cluster switches determining the adaptive mitochondrial and metabolic landscape of breast cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.7559-7559

2024

Volltextzugriff (PDF)

The application of 2D gel-based proteomics methods to the study of breast cancer

Journal of mammary gland biology and neoplasia, 2002-10, Vol.7 (4), p.385-393

2002

Volltextzugriff (PDF)

Cluster analysis of an extensive human breast cancer cell line protein expression map database

Proteomics (Weinheim), 2002-02, Vol.2 (2), p.212-223

2002

Volltextzugriff (PDF)

Disparity between Ki67 measurements and tumor gene expression tests in patients with hormone-sensitive early breast cancer from the OPTIMA preliminary trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.567-567

2022

Volltextzugriff (PDF)

Abstract PD1-11: Mature survival update of the double-blind placebo-controlled randomised phase II PAKT trial of first-line capivasertib plus paclitaxel for metastatic triple-negative breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PD1-11-PD1-11

2021

Volltextzugriff (PDF)

Abstract OT3-17-01: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in mostly node-positive early breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.OT3-17-01-OT3-17-01

2020

Volltextzugriff (PDF)

1 – 25 von 1.739

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.525)
Mit Volltextzugriff
(1.392)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(44)
The Journal Of Urology
(33)
Alzheimer's & Dementia
(32)
Journal Of The American College Of Cardiology
(29)
The New England Journal Of Medicine
(29)
Journal Of Clinical Oncology
(28)
Nature
(25)
Circulation
(20)
Cancer Research
(19)
Nature Genetics
(18)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(15)

Menü

Weitere Dienste

Einstellungen

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial

Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study

Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer

Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework

Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer

Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others

Economic Evaluation of Genomic Test-Directed Chemotherapy for Early-Stage Lymph Node-Positive Breast Cancer

Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study

Multistate Gene Cluster Switches Determine the Adaptive Mitochondrial and Metabolic Landscape of Breast Cancer

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation

Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial

Macroscopic handling and reporting of breast cancer specimens pre- and post-neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches

Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation

OPTIMA (Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis): A prospective trial to validate the predictive utility and cost-effectiveness of gene expression test-directed chemotherapy decisions

Proteomic Definition of Normal Human Luminal and Myoepithelial Breast Cells Purified from Reduction Mammoplasties

Abstract 7559: Multi-state gene cluster switches determining the adaptive mitochondrial and metabolic landscape of breast cancer

The application of 2D gel-based proteomics methods to the study of breast cancer

Cluster analysis of an extensive human breast cancer cell line protein expression map database

Disparity between Ki67 measurements and tumor gene expression tests in patients with hormone-sensitive early breast cancer from the OPTIMA preliminary trial

Abstract PD1-11: Mature survival update of the double-blind placebo-controlled randomised phase II PAKT trial of first-line capivasertib plus paclitaxel for metastatic triple-negative breast cancer

Abstract OT3-17-01: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in mostly node-positive early breast cancer

Suchergebnisse filtern